1. Braun-Falco O, Plewig G, Wolff HH, Burgdorf WHC. Dermatology. New York: Springer, 2000.

2. Weedon D. Skin Pathology. 2nd ed. Sydney: Churchill Livingstone, 2002.

3. Fitzpatrick TB, Freedberg IM, Eisen AZ. Fitzpatrick's Dermatology in General Medicine. New York: McGraw-Hill Education, 2003.

4. Bolognia J, Jorizzo J, Rapini R. Dermatology. St. Louis: Mosby, 2003.

5. Elder DE, Johnson BL, Elenitsas R. Lever's Histopathology of the Skin. Philadelphia: Lippincott Williams & Wilkins, 2005.

6. Ackerman AB, Boer A, Benin B, Gottlieb GJ. Histologic Diagnosis of Inflammatory Skin Diseases. 3rd ed. New York: Ardor Scribendi, 2005.

7. Walker VB. Allergic conditions of the Eye: 1. Rosacea keratitis. Br J Ophthamol. 1948;32(10):759–764.

8. Borrie P. Rosacea with special reference to its ocular manifestations. Br J Dermatol. 1953;65(12):458–463.

9. Jenkins MS, Brown SI et al.: Ocular rosacea. Am J Ophthalmol.,1979;88(3):618–622.

10. Lempert SL, Jenkins MS, Brown SI: Chalazia and Rosacea. Arch. Ophthalmol. 1979;97(9):1652–1653.

11. McCully JP, Sciallis GF: Meibomian keratoconjunctivitis. Am. J. Ophthalmol. 1977;84(6):788–793.

12. McCully JP, Sciallis GF: Meibomian keratoconjunctivitis: oculo-dermal Correlates. CLAO J.,1983;9(2):130–132.

13. Jester JV, Nicolaides N, Smith RE: Meibomian gland studies: histologic and ultrastructural investigations. Invest Ophthalmol Vis Sci. 1981;20(4):537–547.

14. Gutgesell VJ, Stern GA, Hood CI: Histopathology of meibomian gland dysfunction. Am J Ophthalmol. 1982;94(3):383–387.

15. Lemp MA, Mahmood MA, Weiler HH: Association of rosacea with keratoconjunctivitis sicca. Arch Ophthalmol., 1984;102(4):556–557.

16. Robin JB, Jester JV, Nobe J, et al.: In vivo transillumination biomicroscopy and photography of Meibomian gland dysfunction: a clinical Study. Ophthalmol. 1985;92(10):1423–1426.

17. Hoang-Xuang T, Rodriguez A, Zaltas MM, et al.: Ocular rosacea: a histologic and immunopathologic study. Ophthalmol. 1990;97:1468–1475.

18. Gudmundsen KJ, O'Donell BF, Powell FC: Schirmer testing for dry eyes in patients with rosacea. J Am Acad Dermatol. 1992;26:211–214.

19. To KW, Hofmann RJ, Jakobiec FA: Extensive squamous hyperplasia of the Meibomian duct in acne rosacea. Arch Ophthalmol. 1994;112:160–161.

20. Zengin N, Tol H, Gündüz K, et al. : Meibomian gland dysfunction and tear film abnormalities in rosacea. Cornea. 1995;14(2):144–146.

21. Driver PJ, Lemp MA: Meibomian gland dysfunction. Surv Ophthalmol. 1996;40:343–367.

22. Akpek EK, Merchant A, Pinar V, Foster CS. Ocular rosacea, patient characteristics and follow-up. Ophthalmol. 1996; 104(11):1863–1867.

23. Quarterman MJ, Johnson DW, Abele DC, et al. Ocular rosacea. Signs, symptoms, and tear studies before and after treatment with doxycycline. Arch Dermatol. 1997;133(1):49–54. 24 Barton K, Monroy DC, Nava A, Pflugfelder SC: Inflammatory cytokines in the tears of patients with ocular rosacea. Ophthalmol. 1997;104(11):1868–1874.

25. Pisella PJ, Brignole F, Debbasch C, et al.: Flow cytometric analysis of conjunctival epithelium in ocular rosacea and keratoconjunctivitis sicca. Ophthalmol. 2000; 107:1841–1849.

26. Yaylali V, Ozyurt C: Comparison of tear function tests and impression cytology with the ocular findings in acne rosacea. Eur J Ophthalmol. 2002;12(1):11–17.

27. Bron AJ, Tiffany JM. The contribution of meibomian disease to dry eye. Ocul Surf. 2004;2(2):149–165.

28. Baudouin C. A new approach for better comprehension of diseases of the ocular surface. J Fr Ophtalmol. 2007;30(3):239–246.

29. Wilkin JK: Rosacea, pathophysiology and treatment. Arch Dermatol. 1994;130:359–362.

30. Tanzi EL, Weinberg JM: The ocular manifestations of rosacea. Cutis. 2001;68(2):112–114.

31. Michel JL, Cabibel F. Frequency, severity and treatment of ocular rosacea during cutaneous rosacea. Ann Dermatol Venereol. 2003;130(1 Pt 1):20–24.

32. Ghanem VC, Mehra N, Wong S, Mannis MJ. The prevalence of ocular signs in acne rosacea: comparing patients from ophthalmology and dermatology clinics. Cornea. 2003;22(3):230–233.

33. Stone DU, Chodosh J. Ocular rosacea: an update on pathogenesis and therapy. Curr Opin Ophthalmol. 2004;15(6):499–502.

34. Alvarenga LS, Mannis MJ. Ocular rosacea. Ocul Surf. 2005;3(1):41–58.

35. Nazir SA, Murphy S, Siatkowski RM, Chodosh J, Siatkowski RL. Ocular rosacea in childhood. Am J Ophthalmol. 2004;137(1):138–144.

36. Cetinkaya A, Akova YA. Pediatric ocular acne rosacea: long-term treatment with systemic antibiotics. Am J Ophthalmol. 2006;142(5):816–821.

37. Chamaillard M, Mortemousque B, Boralevi F, Marques da Costa C, Aitali F, Taïeb A, Léauté-Labrèze C. Cutaneous and ocular signs of childhood rosacea. Arch Dermato. 2008;144(2):167–171.

38. Ackerman AB, Boer A, Benin B, Gottlieb GJ. Histologic Diagnosis of Inflammatory Skin Diseases. 3rd ed. New York: Ardor Scribendi, 2005.

39. Alvarez D, Böer A. Clinical llassification of rosacea: inconsistencies revealed by clinicopathological correlation. Dermatopathology: Practical and Conceptual. 2008;14(3):6